Published in
American Society for Microbiology, Journal of Virology, 15(95), 2021
DOI: 10.1128/jvi.02350-20
Links
Tools
A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity
Journal article published in 2021 by
Adonis A. Rubio 
,
Maria V. Filsinger Interrante,
Benjamin N. Bell,
Clayton L. Brown,
Theodora U. J. Bruun ,
Celia C. LaBranche ,
David C. Montefiori,
Peter S. Kim
,
Maria V. Filsinger Interrante,
Benjamin N. Bell,
Clayton L. Brown,
Theodora U. J. Bruun ,
Celia C. LaBranche ,
David C. Montefiori,
Peter S. Kim
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Despite advances in antiretroviral therapy, HIV remains a global epidemic and has claimed more than 32 million lives. Accordingly, developing an effective HIV vaccine remains an urgent public health need.